Successful Treatment of Concurrent Follicular Lymphoma and Triple-Negative Breast Cancer Using Rituximab Plus Nab-Paclitaxel and Cisplatin: A Case Report and Literature Review
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Successful Treatment of Concurrent Follicular Lymphoma and Triple-Negative Breast Cancer Using Rituximab Plus Nab-Paclitaxel and Cisplatin: A Case Report and Literature Review
Authors
Keywords
-
Journal
OncoTargets and Therapy
Volume Volume 16, Issue -, Pages 905-911
Publisher
Informa UK Limited
Online
2023-11-01
DOI
10.2147/ott.s430273
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Follicular lymphoma without lymphadenopathy incidentally diagnosed by sentinel lymph node biopsy during breast cancer surgery: a case report
- (2022) Emiko Hiraoka et al. Surgical Case Reports
- Honokiol antagonizes doxorubicin resistance in human breast cancer via miR-188-5p/FBXW7/c-Myc pathway
- (2021) Xianglan Yi et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Synchronous early‑stage breast cancer and axillary follicular lymphoma diagnosed by core needle biopsy: A case report
- (2021) Ryotaro Eto et al. Molecular and Clinical Oncology
- Concurrent Breast Carcinoma and Follicular Lymphoma: A Case Series
- (2021) Tabinda Saleem et al. American Journal of Case Reports
- Homologous Recombination Repair Deficiency and the Immune Response in Breast Cancer: A Literature Review
- (2020) B. Pellegrino et al. Translational Oncology
- TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes
- (2020) Nadine M. Tung et al. JOURNAL OF CLINICAL ONCOLOGY
- Follicular Lymphoma in a Patient with Previously Treated Early Breast Cancer; the Role of PET Imaging and Repeat Tissue Diagnosis
- (2015) Panagiotis Papanastasopoulos et al. Breast Journal
- Multifocal Bilateral Breast Cancer and Breast Follicular Lymphoma: A Simple Coincidence?
- (2015) Adamantios Michalinos et al. Journal of Breast Cancer
- Impact of the Addition of Carboplatin and/or Bevacizumab to Neoadjuvant Once-per-Week Paclitaxel Followed by Dose-Dense Doxorubicin and Cyclophosphamide on Pathologic Complete Response Rates in Stage II to III Triple-Negative Breast Cancer: CALGB 40603 (Alliance)
- (2015) William M. Sikov et al. JOURNAL OF CLINICAL ONCOLOGY
- Concurrent Invasive Ductal Carcinoma of the Breast and Malignant Follicular Lymphoma, Initially Suspected to Be Metastatic Breast Cancer: A Case Report
- (2014) Myong Hun Hahm et al. Journal of Breast Cancer
- Synchronous ipsilateral carcinoma of the accessory mammary gland and primary lymphoma of the breast with subsequent rectal carcinoma: report of a case
- (2014) Akihiro Nishikawa et al. World Journal of Surgical Oncology
- A rare case of non-invasive ductal carcinoma of the breast coexisting with follicular lymphoma: A case report with a review of the literature
- (2014) MIKAKO TAMAOKI et al. Oncology Letters
- The effect of multiple primary rules on population-based cancer survival
- (2013) Hannah K. Weir et al. CANCER CAUSES & CONTROL
- Synchronous breast cancer and lymphoma: a case series and a review of the literature
- (2010) K. E. Cuff et al. JOURNAL OF CLINICAL PATHOLOGY
- Multiple tumours in survival estimates
- (2009) Stefano Rosso et al. EUROPEAN JOURNAL OF CANCER
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer
- (2008) Cornelia Liedtke et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started